CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy.

ABSTRACT:

SUBMITTER: Jain S 

PROVIDER: S-EPMC10007870 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature